SINAGRA, GIANFRANCO
 Distribuzione geografica
Continente #
NA - Nord America 3.326
AS - Asia 1.861
EU - Europa 1.739
SA - Sud America 574
AF - Africa 57
OC - Oceania 4
Totale 7.561
Nazione #
US - Stati Uniti d'America 3.195
SG - Singapore 794
RU - Federazione Russa 640
IT - Italia 461
BR - Brasile 459
CN - Cina 441
VN - Vietnam 284
DE - Germania 177
GB - Regno Unito 108
HK - Hong Kong 92
CA - Canada 81
IE - Irlanda 68
AR - Argentina 56
IN - India 44
PL - Polonia 42
FI - Finlandia 41
FR - Francia 41
MX - Messico 36
ZA - Sudafrica 35
NL - Olanda 34
TR - Turchia 31
ID - Indonesia 30
ES - Italia 25
JP - Giappone 25
SE - Svezia 25
UA - Ucraina 23
EC - Ecuador 22
PK - Pakistan 22
BD - Bangladesh 21
AT - Austria 19
IL - Israele 17
IQ - Iraq 17
LT - Lituania 16
CO - Colombia 13
BE - Belgio 10
UZ - Uzbekistan 10
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
KE - Kenya 7
SA - Arabia Saudita 7
CH - Svizzera 5
CL - Cile 5
OM - Oman 5
PY - Paraguay 5
EG - Egitto 4
NZ - Nuova Zelanda 4
HN - Honduras 3
MA - Marocco 3
PA - Panama 3
UY - Uruguay 3
DO - Repubblica Dominicana 2
DZ - Algeria 2
ET - Etiopia 2
JM - Giamaica 2
KW - Kuwait 2
NP - Nepal 2
PE - Perù 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AL - Albania 1
AZ - Azerbaigian 1
BO - Bolivia 1
BW - Botswana 1
EE - Estonia 1
GD - Grenada 1
HU - Ungheria 1
IR - Iran 1
JO - Giordania 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
PH - Filippine 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
VC - Saint Vincent e Grenadine 1
YE - Yemen 1
Totale 7.561
Città #
Dallas 1.830
Singapore 429
Ashburn 233
Beijing 204
Ho Chi Minh City 111
Moscow 104
Los Angeles 88
Hong Kong 87
Milan 70
Dublin 68
Chandler 60
New York 60
Munich 58
São Paulo 49
Hanoi 46
Hefei 45
Rome 40
Warsaw 36
Santa Clara 35
The Dalles 35
Boardman 31
San Mateo 30
Brooklyn 28
Frankfurt am Main 26
Johannesburg 25
Tokyo 24
Ottawa 23
Beauharnois 22
Denver 22
Fairfield 22
Houston 22
London 21
Montreal 21
Orem 21
Pisa 21
Seattle 21
Buffalo 20
Cambridge 20
Poplar 20
Chennai 18
Lappeenranta 17
Nuremberg 17
Portsmouth 17
Boston 16
West Jordan 16
Istanbul 15
Phoenix 14
Stevenage 14
Tel Aviv 14
Bologna 13
Brasília 13
Helsinki 13
Krefeld 13
Mexico City 13
San Francisco 13
Wilmington 13
Atlanta 12
Belo Horizonte 12
Biên Hòa 12
Querétaro 12
Rio de Janeiro 12
Amsterdam 11
Ankara 11
Florence 11
Haiphong 11
Lawrence 11
Stockholm 11
Turku 11
Bad Bellingen 10
Chicago 10
Dong Ket 10
Porto Alegre 10
Tashkent 10
Buenos Aires 9
Da Nang 9
Genoa 9
Guarulhos 9
Manchester 9
New Delhi 9
Turin 9
Bari 8
Brussels 8
Livorno 8
Nocera Inferiore 8
Washington 8
Guayaquil 7
Nairobi 7
Ninh Bình 7
Vienna 7
Assago 6
Cape Town 6
Guangzhou 6
Lucca 6
Mykolayiv 6
Naples 6
Rawalpindi 6
Redondo Beach 6
Ribeirão Preto 6
Salvador 6
San Diego 6
Totale 4.761
Nome #
High prevalence of wild-type transthyretin cardiac amyloidosis in older adults with carpal tunnel syndrome, heart failure or increased left ventricular mass: The CAPTURE study 661
Impact of GFR Estimation Formulas on MECKI Score Performance and Prognostic Accuracy in Heart Failure: The MECKI-RENAL Study 425
Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis 293
Antithrombotic strategies in the catheterization laboratory for patients with acute coronary syndromes undergoing percutaneous coronary interventions: Insights from the EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in Italian cardiac care units Registry 254
Gender and age normalization and ventilation efficiency during exercise in heart failure with reduced ejection fraction 228
A national survey on prevalence of possible echocardiographic red flags of amyloid cardiomyopathy in consecutive patients undergoing routine echocardiography: study design and patients characterization - the first insight from the AC-TIVE Study 223
[Rationale and significance of the Italian Network for Cardiac Amyloidosis] 223
[Ten perspectives for research and innovation in cardiac amyloidosis] 212
Cardiac and neuromuscular features of patients with LMNA-related cardiomyopathy 203
[Transcatheter devices for chronic heart failure: state of the art] 195
Cardiovascular Death Risk in Recovered Mid-Range Ejection Fraction Heart Failure: Insights From Cardiopulmonary Exercise Test 192
Exploring the Prognostic Performance of MECKI Score in Heart Failure Patients with Non-Valvular Atrial Fibrillation Treated with Edoxaban 182
Roles of periodic breathing and isocapnic buffering period during exercise in heart failure 176
Prognostic Role of Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy and Low-to-Intermediate Sudden Cardiac Death Risk Score 172
Valvular heart disease in patients with cardiac amyloidosis 170
Echocardiographic Biventricular Coupling Index to Predict Precapillary Pulmonary Hypertension 169
[Diagnostic-therapeutic care pathways for patients with cardiac amyloidosis - SIC/ANMCO Consensus document. Edited by the Italian Cardiac Amyloidosis Network (RIAC)] 166
Increased serum uric acid level predicts poor prognosis in mildly severe chronic heart failure with reduced ejection fraction. An analysis from the MECKI score research group 163
Early diagnosis, disease stage and prognosis in wild-type transthyretin amyloid cardiomyopathy: The DIAMOND study 162
Sex differences in the prognostic role of achieving target doses of heart failure medications: Data from the Swedish Heart Failure Registry 158
Percorsi diagnostico-terapeutici assistenziali per i pazienti con amiloidosi cardiaca – Documento di consenso SIC/ANMCO. A cura della Rete Italiana dell’Amiloidosi Cardiaca (RIAC) 158
Exercise oscillatory ventilation and prognosis in heart failure patients with reduced and mid-range ejection fraction 157
Inferior Vena Cava Edge Tracking Echocardiography: A Promising Tool with Applications in Multiple Clinical Settings 157
Critical Comparison of Documents From Scientific Societies on Cardiac Amyloidosis: JACC State-of-the-Art Review 149
Early diagnosis, disease stage and prognosis in wild‐type transthyretin amyloid cardiomyopathy: The DIAMOND study 148
Association between implantable defibrillator-detected sleep apnea and atrial fibrillation: The DASAP-HF study 147
Heart failure patients with improved ejection fraction: Insights from the MECKI score database 145
Unmasking the prevalence of amyloid cardiomyopathy in the real world: results from Phase 2 of the AC-TIVE study, an Italian nationwide survey 144
Redefining the epidemiology of cardiac amyloidosis. A systematic review and meta-analysis of screening studies 134
Old and new equations for maximal heart rate prediction in patients with heart failure and reduced ejection fraction on beta-blockers treatment: results from the MECKI score data set 133
Diagnostic pathways to wild-type transthyretin amyloid cardiomyopathy: a multicentre network study 133
Pressure-volume relationship by pharmacological stress cardiovascular magnetic resonance 126
The chronic heart failure evolutions: Different fates and routes 121
Global Right Heart Assessment with Speckle-Tracking Imaging Improves the Risk Prediction of a Validated Scoring System in Pulmonary Arterial Hypertension 116
Change in prevalence of ATTR variants in Italy: results from a national survey 112
Myocarditis and pericarditis during COVID-19 pandemic: a study of the Italian Society of Cardiology 111
Gamma-glutamyltransferase independently predicts mortality and hospitalization for heart failure in cardiac transthyretin amyloidosis 111
Phenotype and outcomes according to loop diuretic use in pulmonary arterial hypertension 108
Outcome and Disease Progression in NYHA Functional Class I and II Patients With Wild-Type Transthyretin Cardiomyopathy Treated With Tafamidis 106
Left ventricular wall thickness and severity of cardiac disease in women and men with transthyretin amyloidosis 101
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 99
Cardiac amyloidosis: when to suspect and how to confirm 98
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 92
Tafamidis in the Treatment of ATTR-related Cardiomyopathy 70
Cardiac Resynchronization Therapy, Remodeling, and Outcome in Patients With Amyloid Transthyretin Cardiomyopathy 28
Totale 7.631
Categoria #
all - tutte 37.586
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.586


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021101 0 0 0 0 0 0 0 0 48 5 30 18
2021/2022174 19 25 2 19 0 6 19 25 10 28 7 14
2022/2023204 12 21 3 15 22 23 5 23 52 1 17 10
2023/2024332 10 7 39 23 5 16 13 27 43 33 33 83
2024/20251.828 31 81 137 52 112 90 243 397 160 70 265 190
2025/20264.992 322 973 1.817 907 698 275 0 0 0 0 0 0
Totale 7.631